Erlotinib Hydrochloride

A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.

Year introduced: 2016 (1999)

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): D03.633.100.786.375

MeSH Unique ID: D000069347

Registry Number: DA87705X9K

Entry Terms:

• Hydrochloride, Erlotinib
• Erlotinib HCl
• HCl, Erlotinib
• Erlotinib
• N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
• OSI-774
• OSI774
• OSI 774
• Tarceva
• CP 358774
• 358774, CP
• CP-358774
• CP358774
• CP 358,774
• 358,774, CP
• CP-358,774
• CP358,774
• 11C-erlotinib
• 11C erlotinib

Pharmacologic Action:

• Antineoplastic Agents
• Tyrosine Kinase Inhibitors

All MeSH Categories
Chemicals and Drugs Category
Heterocyclic Compounds
Heterocyclic Compounds, Fused-Ring
Heterocyclic Compounds, 2-Ring
Quinazolines
Erlotinib Hydrochloride